Investigational Drug Details
| Drug ID: | D141 |
| Drug Name: | Foralumab |
| Synonyms: | Foralumab |
| Type: | Biological drug |
| DrugBank ID: | DB16170 |
| DrugBank Description: | Foralumab is under investigation in clinical trial NCT03291249 (Assessment of the Safety of Foralumab, an Oral Anti-cd3 Antibody, in Patients With NASH and T2DM). |
| PubChem ID: | -- |
| CasNo: | 946415-64-1 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 withdrawn (NCT03291249: Due to MOH request.) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0526 | NCT03291249 | Phase 2 | Not recruiting | No Results Available | 21/08/2017 | 12 December 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|